The decisions made at the NENC Medicines Subcommittee April 2024 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/
This includes the recommendations made by NTAG at its March 2024 meeting and NICE Technology appraisals from the 1st December 2023 to 31st January 2024.
The following guidelines/position statements were approved and can be found at:
- Free of charge medicines schemes policy https://ntag.nhs.uk/meetings/terms-of-reference-and-membership/ – adopted by NENC Medicines Subcommittee 8th April 2024
- NENC Guideline Development Checklist (updated version) https://ntag.nhs.uk/wp-content/uploads/2024/04/NENC-Guideline-development-checklist.docx
- NENC Abnormal Liver blood test Guidelines NENC Hepatology Network V3.0 (update of previous version) https://ntag.nhs.uk/guidelines/
- NENC Agomelatine – Prescribing and Monitoring in Adults – Information for Primary Care (new) https://ntag.nhs.uk/guidelines/
- NENC Clozapine Supporting guidance for primary care (new) https://ntag.nhs.uk/guidelines/
- NENC guideline for management of osteoporosis in primary care (new) https://ntag.nhs.uk/guidelines/
- NENC Guidelines: Self-Monitoring of Blood Glucose and Ketones in Diabetes (new) https://ntag.nhs.uk/guidelines/
The following guidelines/position statements were archived/deleted from the NTAG website:
- NENC Patient Specific Factors to Consider When Choosing a DOAC in NVAF